BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12355081)

  • 1. Top ten biotechnologies for improving health in developing countries.
    Daar AS; Thorsteinsdóttir H; Martin DK; Smith AC; Nast S; Singer PA
    Nat Genet; 2002 Oct; 32(2):229-32. PubMed ID: 12355081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying genomics-related technologies for Africa's health needs.
    Singer PA; Court EB; Bhatt A; Frew SE; Greenwood H; Persad DL; Salamanca-Buentello F; Séguin B; Taylor AD; Daer HT; Daar AS
    Afr J Med Med Sci; 2007; 36 Suppl():7-14. PubMed ID: 17703557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology and the developing world. Finding ways to bridge the agricultural technology gap.
    Platais KW; Collinson MP
    Finance Dev; 1992 Mar; ():34-6. PubMed ID: 12284926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing genomics and biotechnology to improve global health equity.
    Singer PA; Daar AS
    Science; 2001 Oct; 294(5540):87-9. PubMed ID: 11588248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A decade of child health research in developing countries].
    Orne-Gliemann J; Perez F; Leroy V; Newell ML; Dabis F
    Sante; 2003; 13(2):69-75. PubMed ID: 14530116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The World Health Channel: an innovation for health and development.
    McConnell H; Haile-Mariam T; Rangarajan S
    World Hosp Health Serv; 2004; 40(4):36-9. PubMed ID: 15751552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biotechnology revolution and world health.
    Nossal SG
    Public Health Rep; 1998; 113(2):122-7. PubMed ID: 9719812
    [No Abstract]   [Full Text] [Related]  

  • 9. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project.
    Hotez PJ; Remme JH; Buss P; Alleyne G; Morel C; Breman JG
    Clin Infect Dis; 2004 Mar; 38(6):871-8. PubMed ID: 14999633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related biotechnologies for infectious disease control in Africa: Ethical, Legal and Social Implications (ELSI) of transfer and development.
    Sommerfeld J; Oduola AM
    Afr J Med Med Sci; 2007; 36 Suppl():1-5. PubMed ID: 17703556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Democratizing molecular diagnostics for the developing world.
    Abou Tayoun AN; Burchard PR; Malik I; Scherer A; Tsongalis GJ
    Am J Clin Pathol; 2014 Jan; 141(1):17-24. PubMed ID: 24343733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Consortium on Mental Health Policy and Services: objectives, design and project implementation.
    Gulbinat W; Manderscheid R; Baingana F; Jenkins R; Khandelwal S; Levav I; Lieh Mak F; Mayeya J; Minoletti A; Mubbashar MH; Srinivasa Murthy R; Parameshvara Deva M; Schilder K; Tomov T; Baba A; Townsend C; Whiteford H
    Int Rev Psychiatry; 2004; 16(1-2):5-17. PubMed ID: 15276933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries.
    Levine OS; Cherian T; Shah R; Batson A
    J Health Popul Nutr; 2004 Sep; 22(3):268-74. PubMed ID: 15609779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy and ethical issues in applying medical biotechnology in developing countries.
    Bhardwaj M; Macer DR
    Med Sci Monit; 2003 Feb; 9(2):RA49-54. PubMed ID: 12601306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional and international approaches on prevention and control of animal transboundary and emerging diseases.
    Domenech J; Lubroth J; Eddi C; Martin V; Roger F
    Ann N Y Acad Sci; 2006 Oct; 1081():90-107. PubMed ID: 17135498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnology to improve health in developing countries -- a review.
    Acharya T; Kennedy R; Daar AS; Singer PA
    Mem Inst Oswaldo Cruz; 2004 Jun; 99(4):341-50. PubMed ID: 15322621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case studies on the use of biotechnologies and on biosafety provisions in four African countries.
    Black R; Fava F; Mattei N; Robert V; Seal S; Verdier V
    J Biotechnol; 2011 Dec; 156(4):370-81. PubMed ID: 21763362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based public health: what does it offer developing countries?
    McMichael C; Waters E; Volmink J
    J Public Health (Oxf); 2005 Jun; 27(2):215-21. PubMed ID: 15820994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.